PPL
57
2
NDAQ
77
3
SE
54
5
KO
46
2
ED
42
5
PRGO
43
4
MCO
70
5
NUE
54
-4
M
53
-5
TROW
62
6
ITW
40
3
FITB
78
3
APD
50
5
MO
54
3
BWA
55
2
MS
76
2
ETR
49
2
WHR
48
-2
MTCH
70
11
AAL
57
3
PPL
57
2
NDAQ
77
3
SE
54
5
KO
46
2
ED
42
5
PRGO
43
4
MCO
70
5
NUE
54
-4
M
53
-5
TROW
62
6
ITW
40
3
FITB
78
3
APD
50
5
MO
54
3
BWA
55
2
MS
76
2
ETR
49
2
WHR
48
-2
MTCH
70
11
AAL
57
3
Financhill
Back

Gossamer Bio, Inc. 10K Form

Buy
81

GOSS
Gossamer Bio, Inc.

Last Price:
$3.42
Seasonality Move:
1.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GOSS News And Ratings

See the #1 stock for the next 7 days that we like better than GOSS

GOSS Financial Statistics

Sales & Book Value

Annual Sales: $114.7M
Cash Flow: $-36.2M
Price / Cash Flow: 54.59
Annual Sales: $-0.36
Price / Book: 8.01

Profitability

EPS (TTM): -0.68720
Net Income (TTM): $-156.2M
Gross Margin: $110.6M
Return on Equity: -615%
Return on Assets: -55.91%

Gossamer Bio, Inc. Earnings Forecast

Key Gossamer Bio, Inc. Financial Ratios

  • The Gross Profit Margin over the past 4 years for GOSS is 96.38%.
  • The Selling, General & Administrative Expenses for GOSS have been equal to 31.50% of Gross Profit Margin.
  • The Research & Development expenses have been 120.01% of Revenue.
  • The Net Earning history of GOSS is -49.28% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

Gossamer Bio, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GOSS
CUSIP: 38341P
Website: gossamerbio.com

Debt

Debt-to-Equity Ratio: -2.46
Current Ratio: 3.28
Quick Ratio: 3.05

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GOSS Technical Analysis vs Fundamental Analysis

Buy
81
Gossamer Bio, Inc. (GOSS) is a Buy

Is Gossamer Bio, Inc. a Buy or a Sell?